Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
Open Access
- 4 October 2015
- journal article
- research article
- Published by Elsevier BV in The Lancet Infectious Diseases
- Vol. 16 (1), 61-69
- https://doi.org/10.1016/s1473-3099(15)00320-5
Abstract
No abstract availableFunding Information
- Wellcome Trust (grant number 095909/Z/11/Z)
This publication has 42 references indexed in Scilit:
- First‐in‐man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarialsBritish Journal of Clinical Pharmacology, 2013
- Factors associated with non-adherence to Artemisinin-based combination therapy (ACT) to malaria in a rural population from holoendemic region of western KenyaBMC Infectious Diseases, 2012
- The WWARN Antimalarial Quality SurveyorPathogens and Global Health, 2012
- Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated MalariaAntimicrobial Agents and Chemotherapy, 2012
- Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimatorMalaria Journal, 2011
- Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administrationMalaria Journal, 2011
- Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malariaProceedings of the National Academy of Sciences, 2011
- Drug-Resistant Malaria: The Era of ACTCurrent Infectious Disease Reports, 2010
- Artemisinins: their growing importance in medicineTrends in Pharmacological Sciences, 2008
- The Fe2+‐Mediated Decomposition, PfATP6 Binding, and Antimalarial Activities of Artemisone and Other Artemisinins: The Unlikelihood of C‐Centered Radicals as Bioactive IntermediatesChemMedChem, 2007